Contineum Therapeutics, Inc. (CTNM) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $260.99M | +31.8% |
| 2024 | $198.07M | +391.5% |
| 2023 | -$67.94M | +27.1% |
| 2022 | -$93.21M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $260.99M | +31.8% |
| 2024 | $198.07M | +391.5% |
| 2023 | -$67.94M | +27.1% |
| 2022 | -$93.21M | — |